Erdosteine Suppliers & Bulk Manufacturers
Available Forms: Tablets / Capsules / oral suspension
Available Strengths: 300mg, 175 mg/5 mL
Reference Brands: Erdotin (EU), Esteclin (EU)
Category:
Respiratory Disorder
Erdosteine is a mucolytic agent used to treat respiratory conditions characterized by thickened mucus, such as chronic bronchitis and chronic obstructive pulmonary disease (COPD). It works by breaking down the disulfide bonds in mucus, making it less viscous and easier to expel. Erdosteine also exhibits antioxidant and anti-inflammatory properties, which may help reduce oxidative stress and inflammation in the airways.
Erdosteine is available in Tablets / Capsules / oral suspension
and strengths such as 300mg, 175 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Erdosteine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Erdosteine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing